Journal of Neuroimmune Pharmacology

Aims & Scope

The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system.

The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes.

The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity.

Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome.

JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.5
2024	5.20

Journal Rank

Year	Value
2024	3297

Journal Citation Indicator

Year	Value
2024	735

SJR (SCImago Journal Rank)

Year	Value
2024	1.251

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	94

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology, Medicine, Neuroscience and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions

  Citation: 743

  Authors: Yuri, Servio H., James, Georgette D.

• Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain

  Citation: 715

  Authors: Carol A.

• Microglia Biology in Health and Disease

  Citation: 412

  Authors: Gwenn A., Thomas

• The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections

  Citation: 410

  Authors: Jatin, Jonathan, Ahmed M., Debashis, Barnali, Maxim D., Wilson R., Douglas D., Mahmudul, Milankumar, Peter, Raymond Chuen-Chung, Linda, Howard E., Bhavesh D.

• Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation

  Citation: 333

  Authors: S., Vidhu, Sabita

• Stress-Induced Immune Dysregulation: Implications for Wound Healing, Infectious Disease and Cancer

  Citation: 306

  Authors: Jonathan P., Ronald

• Central Mechanisms of Pain Revealed Through Functional and Structural MRI

  Citation: 291

  Authors: Karen D., Massieh

• Tumor Necrosis Factor-alpha and the Roles it Plays in Homeostatic and Degenerative Processes Within the Central Nervous System

  Citation: 286

  Authors: Sara L., William J.

• CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease

  Citation: 285

  Authors: Jessica A. Hutter, Katherine A., Lisa M., Heather E., Kathryn M., Diego R., Jane L., Pamela M., John M., Daniel L., Hesham H., David G., R. Lee, Howard E.

• Microglia in ALS: The Good, The Bad, and The Resting

  Citation: 283

  Authors: Jenny S., David R., Weihua, Stanley H.

---